Exacerbation of hepatitis B infection following cessation of lamivudine therapy

被引:2
作者
Barlow, GD [1 ]
France, AJ [1 ]
机构
[1] Kings Cross Hosp, Dept Infect & Immunodeficiency, Dundee DD3 8EA, Scotland
关键词
D O I
10.1258/0956462001914931
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:684 / 684
页数:1
相关论文
共 4 条
[1]   Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine [J].
Bessesen, M ;
Ives, D ;
Condreay, L ;
Lawrence, S ;
Sherman, KE .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1032-1035
[2]  
*GLAX UK LTD, 2000, P EPX ROUNDT M GLAX, P14
[3]   The need to exercise caution in the management of patients co-infected with HIV and hepatitis B [J].
Joseph, AT ;
Chandramani, S ;
Cox, M .
INTERNATIONAL JOURNAL OF STD & AIDS, 2000, 11 (02) :131-132
[4]   Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy [J].
Proia, LA ;
Ngui, SL ;
Kaur, S ;
Kessler, HA ;
Trenholme, GM .
AMERICAN JOURNAL OF MEDICINE, 2000, 108 (03) :249-251